Quick Links
Meet
the Commercial Team
Super User
Ovine Ecthyma Vaccine
Ovine Ecthyma Vaccine
We have been producing an Ovine Ecthyma vaccine (commonly referred to as ‘sore mouth vaccine’) in concert with Texas A&M AgriLife Extension Services since 2015 mainly for the sheep producing community in the Southwestern United States.
This is a live virus vaccine and is produced using scabs collected from animals that have been inoculated with the virus. After collection, it is put through the production process to manufacture batches of the vaccine and samples from each batch are put through a live-animal efficacy test—using animals that have not been previously exposed to the virus—to ensure the vaccine is doing what it is supposed to do before being released to sheep producers for use in their flocks.
The live virus vaccine aids in the prevention of soremouth caused by Ovine Ecthyma. To administer, restrain the lamb then scarify a 3/4” X 3/4” area on the inner thigh. Use the rubber serum stopper on the glycerin bottle to dispense the vaccine onto scarified area. Do not vaccinate within 21 days of slaughter.
DOWNLOAD | Ovine Ecthyma LABEL
Commercial Cattle Vaccines
WHEN IT COMES TO BRD,
PREVENTION IS GENERALLY MORE COST EFFECTIVE THAN TREATMENT
Bovine Respiratory Disease (BRD), also known as "shipping fever", is a costly disease that affects cattle throughout the United States across all segments of the industry. While there are many factors that contribute to its development and progression, decades of research have identified five viruses and five bacteria as the predominate disease-causing pathogens associated with the complex disease. Read
BRD Associated Viruses
- Parainfluenza 3 (PI3)
- Bovine Viral Diarrhea (BVD) Type 1
- Bovine Viral Diarrhea (BVD) Type 2
- Bovine Respiratory Syncytial Virus (BRSV)
- Bovine Rhinotracheitis (IBR)
BRD Associated Bacteria
- Mannheimia (Pasteurella) haemolytica Type A1
- Mannheimia (Pasteurella) haemolytica Type A6
- Pasteurella multocida
- Mycoplasma bovis
- Haemophilus somnus
There are a lot of variables that need to be considered when building the right vaccination protocol for your operation. Making sure your vaccine protocol is covering the most common viral and bacterial contributors to the disease is a good start. Ultimately, at the end of the day, it is important to choose the right products, give them the right way and at the right time.
All of our commercial cattle vaccines were developed specifically for stocker and feeder cattle to provide protection against all 10 of the most common BRD-causing pathogens. They are available in a variety of different combinations and presentations to meet your operations’ specific needs.
We recommend working with your veterinarian to build an effective vaccination protocol specifically for your operation.
| Product Name | Available Sizes | Antigens | ||||||
|---|---|---|---|---|---|---|---|---|
| BVD I | BVD II | IBR | PI3 | BRSV | Mh | Pm | ||
 |
50 dose | |||||||
 |
50 dose | |||||||
 |
50 dose | |||||||
 |
50 dose | |||||||
 |
10 dose 50 dose |
|||||||
 |
10 dose 50 dose |
|||||||
| Product Name | Available Sizes | Antigens | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Mh A1 | Mh A6 | Pm | Hs | St | Mb | IBR | BVD | ||
 |
50 dose 100 dose |
||||||||
PMH-BAC™ |
10 dose 50 dose |
||||||||
 |
50 dose 100 dose |
||||||||
 |
50 dose 100 dose |
||||||||
 |
50 dose 100 dose |
||||||||
 |
50 dose 100 dose |
||||||||
 |
50 dose 100 dose |
||||||||
Davis Becker
Regional Territory Sales Accounts Manager
Northeast Iowa, Illinois & Wisconsin
Shane Strickler
Senior Territory Manager
California, Nevada & South Oregon
Robert Boley
Senior Territory Manager
South / East Texas
PROMOTION ANNOUNCEMENT: Dr. Dave Ellefson
It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the past 12 years and during his tenure, has provided world-class technical services support for our business. As Bimeda continues to grow and expand our technical services department, Dr. Dave is perfect for leading our North American Technical Services Team.
Dr. Dave’s main job responsibilities will be:
- Provide technical support for all field sales specialists in all species in North America
- Manage the Field Technical Services Veterinarians that support the commercial business
- Provide input and oversight of post-approval commercial trials
- Provide input and oversight on pre-approval vaccine R&D projects
- Provide guidance, support, and input on the recently acquired AquaTactics business.
Please join me in congratulating Dr. Dave on his new role and challenge.
Dave Cunningham
Chief Commercial Officer, Bimeda US
Bimeda Welcomes Dr. Chris Thomsen
Bimeda is pleased to announce the addition of Dr. Chris Thomsen in the role of field based Technical Services Veterinarian, with a focus on beef cattle. Dr. Thomsen will also assist with Equine Technical Services.
Dr. Thomsen has 21 years of large animal veterinary experience. He has spent 3 years in large animal private practice in western Kansas focusing on feed yard consultation and cow-calf practice and 12 years as a partner in a mixed animal practice, with a focus on cow-calf production medicine. In 2015, Dr. Thomsen began working in the animal health industry as a beef cattle technical services veterinarian.
Bimeda is proud to welcome Dr. Thomsen as an integral part of our Technical Services Team.
Dr. Chris Thomsen
Technical Services Veterinarian
Tim Blackstone
Senior Territory Manager
Minnesota, North Dakota & South Dakota
Ben Siegfried
Senior Territory Manager
Nebraska, Iowa
Bimeda USA
Bimeda® Biologicals
1702 North Bell Street,
San Angelo, Texas
76903
Phone: 1 800 284 8403
NO SMOKE & MIRRORS.
JUST SOLID SCIENCE.
Stimulator® vaccines were designed to stimulate a strong, protective immune response in stocker and feeder cattle against the five most common viral pathogens associated with Bovine Respiratory Disease (BRD):
- Infectious Bovine Rhinotracheitis (IBR)
- Bovine Viral Diarrhea Type 1 (BVD I)
- Bovine Viral Diarrhea Type 2 (BVD I)
- Bovine Respiratory Syncytial Virus (BRSV)
- Parainfluenza3 (PI3)
DOWNLOAD | STIMULATOR DETAILER
Why Choose Stimulator Vaccines?
RELEVANT
Stimulator vaccines were developed 10-20 years after most other commonly used straight MLV vaccines. As a result, an additional decade’s worth (or more) of insights and understanding were used to build Stimulator vaccines. We selected strains to maximize cross-protection against the most prevalent subtypes affecting your cattle.
QUALITY
All viral antigens contained in Stimulator vaccines have been genetically tested to confirm stability and purity to ensure they have not mutated during the production process.
SAFE
Unlike most MLV’s for cattle, no fetal bovine serum is used at any stage of production of the viruses or the cells contained in Stimulator vaccines. This guarantees that no extraneous, unwanted bovine viruses are introduced from fetal bovine serum.
EFFICACY
Stimulates protective immunity so your cattle are better equipped to remain healthy and productive when faced with common viral challenges.
PROTECT YOUR CATTLE AND YOUR
BOTTOM LINE.
Our PRO-BAC™ vaccine line was developed specifically for stocker and feeder cattle and offers the most complete protection against five of the most common BRD-causing bacteria:
- Mannheimia haemolytica Type A1 (MhA1)
- Mannheimia haemolytica Type A6 (MhA6)
- Pasteurella multocida (Pm)
- Histophilus somni / Haemophilus somnus (Hs)
- Salmonella typhimurium (St)
No other vaccines available on the market can say the same.
All of the PRO-BAC vaccines are powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS Advantage
DOWNLOAD PRO-BAC - FEATURES, BENEFITS & COMPARISONS TO OTHER PRODUCTS PRO-BAC - OVERVIEW & IMPORTANCE OF PREVENTION PRO-BAC ADMINISTRATION GUIDE
Why Choose PRO‑BAC VACCINES?
QUALITY BACTERIAL ANTIGENS
Our antigens are grown in specific conditions to maximize expression of all virulence factors, which optimizes post-injection antigen presentation in order to elicit a stronger immune response to better protect your cattle against the bacterial challenges they may face later on—whether that is on the ranch or in the feedlot.
CONVENIENCE
Available in both 50-dose and 100-dose bottles, PRO-BAC vaccines come ready-to-use requiring no chute-side mixing and are administered in a BQA-friendly 2.0 mL subcutaneous (SQ) dose in the side of the neck.
VERSATILITY
Choose the right antigen combination to plug into your current vaccination protocol to fill the gaps other vaccines aren’t covering to set your calves up to perform on the ranch and in the feedlot.
EFFICACY
Our unique manufacturing process and proprietary adjuvant system (Reveal ATS™) results in vaccines that provide a high level of protection against the costliest BRD-causing bacteria without the harsh side effects often associated with the vaccination of mid- to high-risk cattle.
Learn more about the Reveal ATS Advantage
DEALING WITH HIGH PULL RATES, POOR TREATMENT RESPONSE AND SWOLLEN JOINTS IN RECENTLEY WEANED CALVES?
YOUR VACCINE PROTOCOL MAY BE MISSING A KEY PIECE.
Mycoplasma bovis is one of the most prevalent of all the bacterial pathogens affecting young cattle during periods of elevated stress such as weaning and transportation. In general, the higher the “risk classification” of a particular group of cattle the greater the possibility of a Mycoplasma problem. Read
The typical “myco” infections begin to show up about 3 weeks after exposure and can cause respiratory disease as well as crippling arthritis. Due to it’s extremely small cell size and lack of a ridged cell wall, many antibiotics are rendered ineffective against M. bovis resulting in increased pull rates, poor treatment response and unusually high death rates.
MYCO-BAC® was the first fully licensed Mycoplasma bovis (also referred to as ‘Mycoplasma’ or ‘Myco’) vaccine approved by the USDA in 2002. It was originally developed by the team at Texas Vet Lab, Inc. following years of clinical observation and diagnostic/laboratory research as well as significant experience producing effective autogenous vaccines for feedlot and stocker veterinarians and consultants from across the country.
MYCO-BAC is powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS Advantage
DOWNLOAD | MYCO-BAC LABEL
The Benefits of Vaccinating with MYCO‑BAC
COST SAVINGS
When it comes to Mycoplasma bovis, prevention is almost always cheaper than treatment. Not only will a myco infection negatively impact cattle’s’ performance by keeping them off feed and water, effective treatment options are limited which often leads to high labor and drug expenses.
REDUCED MORBIDITY & MORTALITY
Field trials coupled with expansive experience and understanding of the disease support that giving MYCO-BAC, according to the labeled 3-dose regiment administered on days 0, 7 and 14, will reduce morbidity and mortality as well as increase treatment response success in vaccinated cattle.
EFFECTIVE
Our unique manufacturing process combines quality bacterial antigen with our proprietary adjuvant system (Reveal ATS™) to create a strong, specific immune response to prevent and control respiratory disease due to M. bovis.
Learn more about the Reveal ATS™ Advantage
PREVENTING THE PREVENTABLE
WITH AN EFFECTIVE COMBINATION.
An effective combination vaccine that helps protect cattle against some of the most common—and costly—viral and bacterial pathogens associated with Bovine Respiratory Disease (BRD).
Available Sizes
10 dose, 50 dose
DOWNLOAD | STIMULATOR 5 + PMH DETAILER